MeSH term
Frequency | Condition_Probility | Antigens, CD95/physiology | 2 | 2.0 |
Caspases/metabolism | 3 | 0.0 |
Enzyme Activation | 8 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Humans | 86 | 0.0 |
*I-kappa B | 3 | 1.0 |
NF-kappa B/*physiology | 5 | 5.0 |
Research Support, Non-U.S. Gov't | 47 | 0.0 |
Sequence Deletion | 7 | 0.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 2 | 0.0 |
Animals | 29 | 0.0 |
Apoptosis/*physiology | 3 | 0.0 |
Proteins/metabolism | 9 | 0.0 |
*Signal Transduction | 7 | 0.0 |
TNF Receptor-Associated Factor 1 | 55 | 35.0 |
Research Support, U.S. Gov't, P.H.S. | 29 | 0.0 |
Antigens, CD/*metabolism | 2 | 0.0 |
Apoptosis | 6 | 0.0 |
Cell Line | 21 | 0.0 |
Hela Cells | 11 | 0.0 |
Jurkat Cells | 6 | 0.0 |
Protein Binding | 16 | 0.0 |
Proteins/*metabolism | 10 | 1.0 |
Receptors, Tumor Necrosis Factor/*metabolism | 7 | 3.0 |
Receptors, Tumor Necrosis Factor, Type II | 3 | 1.0 |
Signal Transduction | 23 | 0.0 |
TNF Receptor-Associated Factor 2 | 35 | 16.0 |
Blotting, Western | 5 | 0.0 |
Gene Deletion | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Mutation | 2 | 0.0 |
Plasmids/genetics | 2 | 0.0 |
Tumor Cells, Cultured | 21 | 0.0 |
B-Lymphocytes/metabolism | 3 | 1.0 |
Cell Line, Transformed | 3 | 0.0 |
*Cell Transformation, Viral | 3 | 1.0 |
*Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
*Protein Biosynthesis | 2 | 0.0 |
Receptors, Tumor Necrosis Factor | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Up-Regulation | 4 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Viral Matrix Proteins/*metabolism | 4 | 16.0 |
Antigens, CD95/*metabolism | 2 | 1.0 |
Apoptosis/drug effects/*physiology | 3 | 1.0 |
Cells, Cultured | 5 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 3 | 0.0 |
NF-kappa B/genetics/*metabolism | 2 | 2.0 |
Proteins/genetics/metabolism | 3 | 1.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Comparative Study | 8 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
Organ Specificity | 3 | 0.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 2 | 0.0 |
Epstein-Barr Virus Infections/*metabolism | 3 | 50.0 |
Female | 5 | 0.0 |
Male | 2 | 0.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
NF-kappa B/*metabolism | 12 | 2.0 |
Receptors, Tumor Necrosis Factor/genetics | 3 | 6.0 |
Tumor Necrosis Factor-alpha/pharmacology | 5 | 0.0 |
Apoptosis/*genetics | 3 | 1.0 |
Base Sequence | 13 | 0.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Amino Acid Sequence | 22 | 0.0 |
Cytosol/metabolism | 2 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
NF-kappa B/metabolism | 10 | 1.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Receptors, Tumor Necrosis Factor/metabolism | 6 | 3.0 |
Sequence Homology, Amino Acid | 14 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
Mice | 20 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Proteins/*genetics | 4 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Species Specificity | 2 | 0.0 |
TNF Receptor-Associated Factor 3 | 19 | 27.0 |
TNF Receptor-Associated Factor 5 | 5 | 15.0 |
TNF Receptor-Associated Factor 6 | 7 | 5.0 |
Flavonoids/pharmacology | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 4 | 0.0 |
Neoplasm Proteins/genetics/metabolism | 2 | 1.0 |
Protein Biosynthesis | 6 | 0.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors | 2 | 2.0 |
Proteins/genetics | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 4 | 0.0 |
Binding Sites | 14 | 0.0 |
Caspases/*metabolism | 4 | 1.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Proteins/genetics/*metabolism | 8 | 1.0 |
Signal Transduction/physiology | 3 | 0.0 |
Herpesvirus 4, Human/genetics | 2 | 2.0 |
*Apoptosis | 7 | 0.0 |
Tumor Necrosis Factor-alpha/*physiology | 7 | 2.0 |
Blotting, Northern | 5 | 0.0 |
DNA/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Transfection | 11 | 0.0 |
Protein Conformation | 2 | 0.0 |
Receptors, Tumor Necrosis Factor/physiology | 3 | 4.0 |
*Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 6 | 24.0 |
Apoptosis/*drug effects | 2 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Antigens, CD95/*physiology | 2 | 2.0 |
Antigens, CD30/*metabolism | 2 | 25.0 |
Immunoblotting | 2 | 0.0 |
Precipitin Tests | 5 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Cell Division | 3 | 0.0 |
Herpesvirus 4, Human/*genetics | 2 | 2.0 |
*Homeodomain Proteins | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 5 | 0.0 |
Phosphorylation | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Viral Matrix Proteins/*genetics/metabolism | 2 | 50.0 |
*Gene Expression Regulation | 3 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Kinetics | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Models, Chemical | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Proteins/chemistry/genetics/*metabolism | 2 | 2.0 |
Binding, Competitive | 3 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 5 | 1.0 |
Receptors, Tumor Necrosis Factor/genetics/*metabolism | 4 | 11.0 |
Chromosome Mapping | 2 | 0.0 |
*Herpesvirus 4, Human | 2 | 5.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
*Up-Regulation | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Sequence Alignment | 6 | 0.0 |
Antigens, CD40/*physiology | 2 | 5.0 |
DNA Mutational Analysis | 2 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Gene Expression Regulation | 6 | 0.0 |
DNA Primers | 2 | 0.0 |
*Antigens, CD | 2 | 0.0 |
Proteins/*physiology | 2 | 1.0 |
Signal Transduction/*physiology | 4 | 0.0 |
*Proteins | 2 | 0.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
Herpesvirus 4, Human/*metabolism | 2 | 4.0 |
*Caspases | 2 | 3.0 |
Binding Sites/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 2 | 1.0 |
Receptors, Nerve Growth Factor/genetics/*metabolism | 2 | 12.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Cytoplasm/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Luciferases/genetics | 2 | 0.0 |
NF-kappa B/genetics | 2 | 5.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Viral Matrix Proteins/*physiology | 3 | 27.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Zinc Fingers | 4 | 0.0 |
NF-kappa B/*antagonists & inhibitors | 3 | 6.0 |
Luciferases/metabolism | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis/metabolism | 2 | 2.0 |
Antigens, CD40 | 2 | 3.0 |
Gene Expression | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Luminescent Proteins/genetics | 2 | 1.0 |
Adult | 2 | 0.0 |
Aged | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
